|
BILOBALIDE |
| (5aR-(3aS*,5aalpha,8beta,8aS*,9alpha,10aalpha))-9-(1,1-Dimethylethyl)-10,10a-dihydro-8,9-dihydroxy- 4H,5aH,9H-furo(2,3-b)furo(3',2':2,3)cyclopenta(1,2-c)furan-2,4,7(3H,8H)-trione; |
|
|
| PRODUCT IDENTIFICATION |
|
|
CAS RN |
33570-04-6 |
|
EINECS RN |
|
|
FORMULA |
C15H18O8 |
|
MOLE WEIGHT |
326.30 |
|
|
| PHYSICAL AND CHEMICAL PROPERTIES |
|
|
PHYSICAL STATE |
white to off-white powder |
|
MELTING POINT |
|
|
BOILING POINT |
|
|
DENSITY |
|
|
SOLUBILITY IN WATER |
(Soluble in alcohol, DMSO) |
|
pH |
|
|
VAPOR DENSITY |
|
|
REFRACTIVE INDEX |
|
|
FLASH POINT |
|
|
|
| STABILITY AND REACTIVITY | |
| STABILITY | Stable under normal conditions. |
|
INCOMPATIBLE MATERIALS |
Strong oxidizing agents |
| DECOMPOSITION PRODUCTS |
Carbon oxides |
| POLYMERIZATION | Has not been reported |
|
NFPA RATINGS |
Health: , Flammability: , Reactivity: |
|
|
| SAFETY |
|
|
HAZARD NOTES |
Irritant |
|
EYE |
May cause eye irritation. |
|
SKIN |
May be harmful if absorbed through skin. May cause skin irritation. |
|
INGESTION |
May be harmful if swallowed. |
|
INHALATION |
May be harmful if inhaled. May cause respiratory tract irritation. |
|
CHRONIC |
|
|
|
| TRANSPORT & REGULATORY INFORMATION |
|
|
UN NO. |
|
| HAZARD CLASS |
|
| PACKING GROUP |
|
| HAZARD SYMBOL |
XI |
|
RISK PHRASES |
36/37/38 |
|
SAFETY PHRASES |
22-24/25 |
|
|
| EXTERNAL LINKS & GENERAL INFORMATION |
| Ginkgo biloba extract contain specific terpenoids called ginkgolides (ginkgolide A, ginkgolide B, ginkgolide C - diterpenes) and bilobalide (pentanorditerpene). Ginkgolide A (GA) and ginkgolide B (GB) are the main molecular forms of ginkgolides. These compounds are non-competitive antagonists of the GABAA and glycine receptors, and are structurally related to picrotoxin (PTX), also a non-competitive antagonist of these receptors. These compounds are thought to bind in the channel of these receptors. The medical benefits of GINKGO BILOBA EXTRACT rely primarily on two groups of active components: the ginkgo flavone glycosides and the terpene lactones. The ginkgo flavone glycoside designation on GBE labels indicates the carefully measured balance of bioflavonoids. These bioflavonoids are primarily responsible for GBE's antioxidant activity and ability to inhibit platelet aggregation. These two actions may help GBE prevent circulatory diseases such as atherosclerosis and support the brain and central nervous system. The unique terpene lactone components found in GBE, known as ginkgolides and bilobalide typically make up 6% of the extract. They are associated with increased circulation to the brain and other parts of the body as well as exert a protective action on nerve cells. Ginkgolides may improve circulation and inhibit platelet-activating factor. Bilobalide is known to protect the cells of the nervous system. |
|
|
| SALES SPECIFICATION |
|
|
APPEARANCE |
white to off-white powder |
|
CONTENT |
98.0% min |
|
|
| PACKING |
|
|
|
|
| PRICE INFORMATION |
 |
